Kegg medicus dgroup
| DG01913 | |
| DG番号 | DG01913 |
| 分類 | DGroup |
| 名称 | ABCG2 substrate TYPE Metabolism |
| ステム | - |
| 構造式 |  |
| メンバー | D00448 Sulfasalazine (USP/INN); Salazosulfapyridine (JP18) D10588 Empagliflozin and linagliptin D10459 Empagliflozin (JAN/USAN/INN) D07086 Rivaroxaban (JAN/USAN/INN) D03213 Apixaban (JAN/USAN/INN) D10593 Roxadustat (JAN/USAN/INN) DG03079 Berotralstat D11673 Berotralstat (USAN/INN) D11674 Berotralstat hydrochloride (JAN/USAN) D09572 Riociguat (JAN/USAN/INN) DG01544 Olmesartan D05246 Olmesartan (USAN/INN) D01204 Olmesartan medoxomil (JP18/USP) DG00355 Atorvastatin D07474 Atorvastatin (INN) D00887 Atorvastatin calcium anhydorous D02258 Atorvastatin calcium (USP); Atorvastatin calcium hydrate (JP18) D11095 Atorvastatin calcium propylene glycol solvate DG00357 Rosuvastatin D08492 Rosuvastatin (INN) D01915 Rosuvastatin calcium (JP18/USP) D10428 Tenofovir alafenamide (USAN/INN) D10605 Tenofovir alafenamide fumarate (JAN/USAN) D10366 Sofosbuvir (JAN/USAN/INN) D10578 Ledipasvir and sofosbuvir D10582 Dasabuvir, ombitasvir, paritaprevir and ritonavir D10745 Ombitasvir, paritaprevir and ritonavir D10827 Sofosbuvir and velpatasvir D11014 Glecaprevir and pibrentasvir D10882 Daclatasvir, asunaprevir and beclabuvir DG00725 Topotecan D08618 Topotecan (BAN) D02168 Topotecan hydrochloride (USAN); Nogitecan hydrochloride (JAN) DG00701 Mitoxantrone D08224 Mitoxantrone (INN) D02166 Mitoxantrone hydrochloride (JAN/USP) DG00715 Lapatinib D08108 Lapatinib (INN) D04024 Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN) DG00720 Regorafenib D10138 Regorafenib (USAN/INN) D10137 Regorafenib hydrate (JAN) D10308 Baricitinib (JAN/USAN/INN) DG01860 Temsavir D10734 Temsavir (USAN/INN) D10707 Fostemsavir (USAN) D10708 Fostemsavir tromethamine (USAN) D11520 Ezetimibe and rosuvastatin |
| 上位グループ | Transporter substrate |
| 注釈1 | - |
| 注釈2 | - |